Portfolio
Conviction calls.
We invest in companies at the forefront of scientific breakthroughs — precision medicine, AI-embedded drug discovery, biologics, and antimicrobial resistance solutions.
Insilico Medicine
AI-powered drug discovery
$29.0M
Darwin Health
Precision oncology
$23.5M
BioVersys
Novel antibiotics
$28.3M
Dragonfly Therapeutics
Immuno-oncology
$15.0M
Tactogen
Neuropsychiatry
$12.6M
Locus Biosciences
Precision antimicrobials
$8.0M
F2G
Antifungal therapeutics
$16.0M
Molecular Partners
DARPin therapeutics
$9.0M
Selected positions shown. Complete portfolio disclosed under NDA to qualified institutional partners.